These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1716689)

  • 41. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.
    Richman DD; Havlir D; Corbeil J; Looney D; Ignacio C; Spector SA; Sullivan J; Cheeseman S; Barringer K; Pauletti D
    J Virol; 1994 Mar; 68(3):1660-6. PubMed ID: 7509000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of human immunodeficiency virus type 1 clinical isolates with reduced sensitivity to zidovudine and dideoxyinosine by RNA.RNA hybridization.
    Japour AJ; Chatis PA; Eigenrauch HA; Crumpacker CS
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3092-6. PubMed ID: 1707532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A rapid phenotypic assay for detecting multiple nucleoside analogue reverse transcriptase inhibitor-resistant HIV-1 in plasma.
    Qari SH; Winters M; Vandamme AM; Merigan T; Heneine W
    Antivir Ther; 2002 Jun; 7(2):131-9. PubMed ID: 12212925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure.
    Moutouh L; Corbeil J; Richman DD
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6106-11. PubMed ID: 8650227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterosexual transmission of human immunodeficiency virus type 1 variants associated with zidovudine resistance.
    Conlon CP; Klenerman P; Edwards A; Larder BA; Phillips RE
    J Infect Dis; 1994 Feb; 169(2):411-5. PubMed ID: 7508970
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.
    Richman D; Shih CK; Lowy I; Rose J; Prodanovich P; Goff S; Griffin J
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11241-5. PubMed ID: 1722324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy.
    Larder BA; Kemp SD; Harrigan PR
    Science; 1995 Aug; 269(5224):696-9. PubMed ID: 7542804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genotypic evolution of HIV-1 isolates from patients after a switch of therapy from zidovudine to didanosine.
    Masquelier B; Pellegrin I; Ruffault A; Ragnaud JM; Morlat P; Michelet C; Doignon F; Biteau N; Fleury HJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):330-4. PubMed ID: 7533640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals.
    Brindeiro R; Vanderborght B; Caride E; Correa L; Oravec RM; Berro O; Stuyver L; Tanuri A
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1674-80. PubMed ID: 10390221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retroviral recombination can lead to linkage of reverse transcriptase mutations that confer increased zidovudine resistance.
    Kellam P; Larder BA
    J Virol; 1995 Feb; 69(2):669-74. PubMed ID: 7529334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
    Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of discontinuation of zidovudine treatment on zidovudine sensitivity of human immunodeficiency virus type 1 isolates.
    Boucher CA; van Leeuwen R; Kellam P; Schipper P; Tijnagel J; Lange JM; Larder BA
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1525-30. PubMed ID: 8103317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonisotopic hybridization assay for determination of relative amounts of genotypic human immunodeficiency virus type 1 zidovudine resistance.
    Eastman PS; Boyer E; Mole L; Kolberg J; Urdea M; Holodniy M
    J Clin Microbiol; 1995 Oct; 33(10):2777-80. PubMed ID: 8567926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro.
    Harrigan PR; Bloor S; Larder BA
    J Virol; 1998 May; 72(5):3773-8. PubMed ID: 9557659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Stability of human immunodeficiency virus to azidothymidine. II. Kinetic characteristics of "AZT-resistant" mutant forms of reverse transcriptase].
    Pokholok DK; Gudima SO; Memelova LV; Esipov DS; Rechinskiĭ VO; Kochetkov SN
    Biokhimiia; 1996 Jan; 61(1):142-51. PubMed ID: 8679772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of primary resistance to zidovudine and lamivudine in drug-naive human immunodeficiency virus type-1 infected patients: high proportion of reverse transcriptase codon 215 mutant in circulating lymphocytes and free virus.
    Trabaud MA; Leriche-Guerin K; Regis C; Bordes I; Cotte L; Detmer J; Kolberg J; Ritter J; Trépo C
    J Med Virol; 2000 Jul; 61(3):352-9. PubMed ID: 10861645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients.
    Mohri H; Singh MK; Ching WT; Ho DD
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):25-9. PubMed ID: 7678340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predominance of codon 215 mutation in reverse transcriptase-coding region of 3'-azido-3'-deoxythymidine (AZT)-resistant HIV-1 isolates after long-term AZT therapy.
    Kondo M
    Kansenshogaku Zasshi; 1995 Nov; 69(11):1278-85. PubMed ID: 8708409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of zidovudine-selected human immunodeficiency virus type 1 reverse transcriptase amino acid substitutions on processive DNA synthesis and viral replication.
    Caliendo AM; Savara A; An D; DeVore K; Kaplan JC; D'Aquila RT
    J Virol; 1996 Apr; 70(4):2146-53. PubMed ID: 8642636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AZT-related mutation Lys70Arg in reverse transcriptase of human immunodeficiency virus type 1 confers decrease in susceptibility to ddATP in in vitro RT inhibition assay.
    Sharma PL; Chatis PA; Dogon AL; Mayers DL; McCutchan FE; Page C; Crumpacker CS
    Virology; 1996 Sep; 223(2):365-9. PubMed ID: 8806572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.